Biotech Preview

It’s been a tough year for biotech investors. The big caps such as Amgen (Ticker: AMGN) and Genentech (Ticker: DNA) sold off, while some of the mid cap players like Genzyme (Ticker: GENZ) and Gilead (Ticker: GILD) generated decent returns. And how can anyone not enjoy the roller coaster ride with Biogen Idec (Ticker: BIIB)!? I would continue to hold onto the winners from 2007 into 2008. You know what they say; the trend is your friend. We’ll see a glimpse as to what 2008 will look like in the upcoming JP Morgan Healthcare conference. The conference starts on January 7th and many companies will be giving preliminary Q4 and 2008 guidance. So stay tuned…